Callitas Therapeutics Inc (LILY):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Callitas Therapeutics Inc (LILY) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6579
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Callitas Therapeutics Inc (Callitas Therapeutics), formerly M Pharmaceutical Inc, is a drug discovery and development company that offers ground-breaking drug treatments and biomedical technologies. The company’s products include weight management products, infertility products and women’s healthcare products. It also provides comprising ToConceive, C-103 Reformulated Orlistat and Extrinsa. Callitas Therapeutics’ products are used to improve the lives of people facing obesity, infertility and intimacy issues. The company’s ToConceive is a fertility enhancing moisturizer that increases woman’s own natural conception lubrication called transudate to aid in conception and Extrinsa address the lack of female sexual dysfunction solutions and focus on women with orgasm and arousal difficulties. Its topical, local, and non-systemic product is also non-hormonal and does not affect the central nervous system. Callitas Therapeutics is headquartered in Vancouver, British Columbia, Canada.

Callitas Therapeutics Inc (LILY) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Callitas Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Callitas Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Callitas Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Callitas Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Callitas Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Callitas Therapeutics Inc, Medical Equipment, Deal Details 10
Partnerships 10
M Pharma Enters into Licensing Agreement with M Diagnostics 10
Callitas Health Enters into Partnership with NFI Consumer Healthcare 11
Equity Offering 12
M Pharma to Raise USD0.3 Million in Private Placement of Units 12
M Pharma Raises USD0.86 Million in Private Placement of Units 13
M Pharma Raises USD1 Million in Private Placement of Units 14
Debt Offering 15
Callitas Health Raises USD0.1 Million in Private Placement of 10% Debenture Due 2020 15
M Pharma Raises USD1.5 Million in First Tranche of Private Placement of 10% Debentures Due 2019 16
Callitas Therapeutics Inc – Key Competitors 17
Callitas Therapeutics Inc – Key Employees 18
Callitas Therapeutics Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Jun 07, 2018: James Thompson Elevated to President and Chief Executive Officer of Callitas Health 20
Jan 03, 2018: Callitas Announces New Interim CEO 21
Jun 08, 2017: M Pharmaceutical Appoints New Chief Financial Officer 22
Mar 03, 2017: M Pharmaceutical Appoints Kim Whittemore of San Diego, California to Its Board of Directors 23
Feb 21, 2017: M Pharmaceutical Appoints Mr. William A. Rodgers Jr., of Milton, Georgia to Its Board of Directors 24
Feb 13, 2017: M Pharmaceutical Appoints Mr. Gary Thompson President & CEO 25
Legal and Regulatory 26
Sep 15, 2017: M Pharmaceutical Announces Name Change to Callitas Health and Share Consolidation 26
Aug 01, 2017: M Pharmaceutical USA Announces a Change of Name to Callitas Therapeutics 27
Government and Public Interest 28
Sep 18, 2018: Callitas Health Announces Corporate Update 28
Other Significant Developments 29
Apr 19, 2018: Callitas Health Releases Annual Update Letter to Shareholders 29
Mar 05, 2018: Callitas Health Announces New Partnership with NFI Consumer Healthcare’s e.p.t. Pregnancy Test Line 31
Mar 01, 2018: Callitas Health Has Big Plans For Broad Product Portfolio 32
Jul 07, 2017: M pharmaceutical reforecasts 2017 and 2018 revenues upward 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Callitas Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Callitas Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Callitas Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Callitas Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Callitas Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Callitas Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Callitas Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
M Pharma Enters into Licensing Agreement with M Diagnostics 10
Callitas Health Enters into Partnership with NFI Consumer Healthcare 11
M Pharma to Raise USD0.3 Million in Private Placement of Units 12
M Pharma Raises USD0.86 Million in Private Placement of Units 13
M Pharma Raises USD1 Million in Private Placement of Units 14
Callitas Health Raises USD0.1 Million in Private Placement of 10% Debenture Due 2020 15
M Pharma Raises USD1.5 Million in First Tranche of Private Placement of 10% Debentures Due 2019 16
Callitas Therapeutics Inc, Key Competitors 17
Callitas Therapeutics Inc, Key Employees 18
Callitas Therapeutics Inc, Subsidiaries 19

List of Figures
Callitas Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Callitas Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Callitas Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Callitas Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Callitas Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Callitas Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Callitas Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Callitas Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Callitas Therapeutics Inc (LILY):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Flex Ltd.:企業の戦略・SWOT・財務分析
    Flex Ltd. - Strategy, SWOT and Corporate Finance Report Summary Flex Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Sysco Corporation (SYY):企業の財務・戦略的SWOT分析
    Sysco Corporation (SYY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Malayan Insurance Co. Inc.:企業の戦略・SWOT・財務情報
    Malayan Insurance Co. Inc. - Strategy, SWOT and Corporate Finance Report Summary Malayan Insurance Co. Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Viamet Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Viamet Pharmaceuticals Inc (Viamet), a subsidiary of Viamet Pharmaceuticals Holdings LLC, discovers and develops novel medicinal drugs based on metalloenzyme chemistry and biology technology platform. Its product pipeline includes clinical-stage compounds such as VT-1161, an oral inhibitor u …
  • Canadian Natural Resources Ltd (CNQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Natural Resources Ltd (Canadian Natural) is an independent upstream oil and gas company. The company carries out acquisition, exploration, development, production, marketing and sale of crude oil, natural gas and natural gas liquids (NGLs). Canadian Natural’s products include light …
  • Enterprise Products Partners L.P.:企業の戦略・SWOT・財務情報
    Enterprise Products Partners L.P. - Strategy, SWOT and Corporate Finance Report Summary Enterprise Products Partners L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Britannia Industries Limited:企業の戦略・SWOT・財務情報
    Britannia Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Britannia Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • A. Menarini Diagnostics Srl:医療機器:M&Aディール及び事業提携情報
    Summary A. Menarini Diagnostics Srl (Menarini Diagnostics), a subsidiary of A Menarini Industrie Farmaceutiche Riunite Srl is a medical device company that offers in-vitro diagnostic products. The company provides pharmaceutical testing products including home glucose testing products, oral anticoag …
  • Compagnie de Saint-Gobain:企業のM&A・事業提携・投資動向
    Compagnie de Saint-Gobain - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Compagnie de Saint-Gobain Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Axelar AB-製薬・医療分野:企業M&A・提携分析
    Summary Axelar AB (Axelar) is a drug development company that develops various novel anti-cancer treatments. The company develops AXL1717, a novel anti cancer compound that inhibits tumor growth and reduces tumor sizes of malignant cells such as prostate cancer, breast cancer, glioblastoma, sarcoma, …
  • Broadcom Inc (AVGO):企業の財務・戦略的SWOT分析
    Broadcom Inc (AVGO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Japan Tobacco Inc.:企業の戦略・SWOT・財務情報
    Japan Tobacco Inc. - Strategy, SWOT and Corporate Finance Report Summary Japan Tobacco Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • The Broad Institute Inc-製薬・医療分野:企業M&A・提携分析
    Summary The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation, is a non-profit research organization that meets critical challenges in biology and medicine. The institute transforms medicine by utilizing systematic approaches in biological sciences, to speed up the understa …
  • Sunkist Growers Inc:企業の戦略的SWOT分析
    Sunkist Growers Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • University of Maryland Medical Center Corp:企業の戦略的SWOT分析
    University of Maryland Medical Center Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Royal Mail plc (RMG):企業の財務・戦略的SWOT分析
    Royal Mail plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Tata Advanced Systems Ltd:企業の戦略・SWOT・財務情報
    Tata Advanced Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary Tata Advanced Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • DIRECT Pojistovna, a.s.:企業の戦略・SWOT・財務分析
    DIRECT Pojistovna, a.s. - Strategy, SWOT and Corporate Finance Report Summary DIRECT Pojistovna, a.s. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Methanex Corp (MX):企業の財務・戦略的SWOT分析
    Methanex Corp (MX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Applied Maths NV-医療機器分野:企業M&A・提携分析
    Summary Applied Maths NV (Applied Maths), a subsidiary of Biomerieux SA is a healthcare technology company that designs, develops and markets various bioscience software products. The company offers software products which include bionumerics, gelcompar, genemaths xt, kodon and bionumerics 2D. Its b …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆